1. Home
  2. LQDA vs MWH Comparison

LQDA vs MWH Comparison

Compare LQDA & MWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$68.49

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo SOLV Energy Inc. Class A Common Stock

MWH

SOLV Energy Inc. Class A Common Stock

N/A

Current Price

$25.12

Market Cap

5.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
LQDA
MWH
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.1B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
LQDA
MWH
Price
$68.49
$25.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
12
Target Price
★ $41.00
$35.42
AVG Volume (30 Days)
963.9K
★ 1.2M
Earning Date
05-08-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.81
N/A
EPS
★ 1.26
0.11
Revenue
★ $158,320,000.00
N/A
Revenue This Year
$278.87
$51.86
Revenue Next Year
$57.13
$14.78
P/E Ratio
★ $56.31
$227.73
Revenue Growth
★ 1031.18
N/A
52 Week Low
$21.35
$23.83
52 Week High
$93.61
$48.40

Technical Indicators

Market Signals
Indicator
LQDA
MWH
Relative Strength Index (RSI) 47.51 41.83
Support Level $62.86 $23.88
Resistance Level $92.35 $30.74
Average True Range (ATR) 2.78 1.18
MACD 0.69 0.10
Stochastic Oscillator 66.74 26.00

Price Performance

Historical Comparison
LQDA
MWH

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About MWH SOLV Energy Inc. Class A Common Stock

SOLV Energy Inc is a provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. It specializes in designing, building and maintaining utility-scale solar and battery storage projects and related T&D infrastructure. The company's projects include: The Eldorado Solar Project, Gravel Pit Solar Project, and Vikings Solar-plus-Storage Project. It operates in one reportable segment which derives revenue through providing EPC, O&M and Development services throughout the Unites Sates. The company derives maximum of revenue from its EPC contracts.

Share on Social Networks: